{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T11:21:51Z","timestamp":1782127311029,"version":"3.54.5"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,1,29]],"date-time":"2025-01-29T00:00:00Z","timestamp":1738108800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,1,29]],"date-time":"2025-01-29T00:00:00Z","timestamp":1738108800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100016079","name":"Science and Technology Department of Xinjiang Uygur Autonomous Region","doi-asserted-by":"publisher","award":["2022B03005"],"award-info":[{"award-number":["2022B03005"]}],"id":[{"id":"10.13039\/100016079","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016079","name":"Science and Technology Department of Xinjiang Uygur Autonomous Region","doi-asserted-by":"publisher","award":["2022B03005"],"award-info":[{"award-number":["2022B03005"]}],"id":[{"id":"10.13039\/100016079","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-88258-z","type":"journal-article","created":{"date-parts":[[2025,1,29]],"date-time":"2025-01-29T04:33:48Z","timestamp":1738125228000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Halofuginone prevents inflammation and proliferation of high-altitude pulmonary hypertension by inhibiting the TGF-\u03b21\/Smad signaling pathway"],"prefix":"10.1038","volume":"15","author":[{"given":"Jiangtao","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lina","family":"Guan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bohua","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huihua","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guozhu","family":"Xing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yawei","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiufang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qin","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenhui","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yixuan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongfeng","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,29]]},"reference":[{"key":"88258_CR1","doi-asserted-by":"publisher","first-page":"1802040","DOI":"10.1183\/13993003.02040-2018","volume":"53","author":"R Soria","year":"2019","unstructured":"Soria, R., Egger, M., Scherrer, U., Bender, N. & Rimoldi, S. F. Pulmonary arterial pressure at rest and during exercise in chronic mountain sickness: A meta-analysis. Eur. Resp. J. 53, 1802040 (2019).","journal-title":"Eur. Resp. J."},{"key":"88258_CR2","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1183\/09059180.00011104","volume":"18","author":"XQ Xu","year":"2009","unstructured":"Xu, X. Q. & Jing, Z. C. High-altitude pulmonary hypertension. Eur. Respir. Rev. 18, 13\u201317 (2009).","journal-title":"Eur. Respir. Rev."},{"key":"88258_CR3","doi-asserted-by":"publisher","first-page":"1801913","DOI":"10.1183\/13993003.01913-2018","volume":"53","author":"G Simonneau","year":"2019","unstructured":"Simonneau, G. et al. Haemodynamic definitions and updated clinical classification of pulmonary hypertension. Eur. Resp. J. 53, 1801913 (2019).","journal-title":"Eur. Resp. J."},{"key":"88258_CR4","doi-asserted-by":"publisher","first-page":"2743","DOI":"10.1111\/bph.15000","volume":"177","author":"Y Chen","year":"2020","unstructured":"Chen, Y. et al. Tetramethylpyrazine: A promising drug for the treatment of pulmonary hypertension. Br. J. Pharmacol. 177, 2743\u20132764 (2020).","journal-title":"Br. J. Pharmacol."},{"key":"88258_CR5","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.3382\/ps.0581469","volume":"58","author":"SA Edgar","year":"1979","unstructured":"Edgar, S. A. & Flanagan, C. Efficacy of stenorol (Halofuginone). I. Against recent field isolates of six species of chicken Coccidia. Poult. Sci. 58, 1469\u20131475 (1979).","journal-title":"Poult. Sci."},{"key":"88258_CR6","doi-asserted-by":"publisher","first-page":"3549","DOI":"10.2147\/OTT.S92518","volume":"8","author":"R Lin","year":"2015","unstructured":"Lin, R. et al. Inhibition of Tgf-\u0392 signaling with halofuginone can enhance the antitumor effect of irradiation in Lewis lung cancer. Oncotargets Ther. 8, 3549\u20133559 (2015).","journal-title":"Oncotargets Ther."},{"key":"88258_CR7","doi-asserted-by":"publisher","first-page":"6247","DOI":"10.1158\/0008-5472.CAN-12-1444","volume":"72","author":"P Juarez","year":"2012","unstructured":"Juarez, P. et al. Halofuginone inhibits the establishment and progression of melanoma bone metastases. Cancer Res. 72, 6247\u20136256 (2012).","journal-title":"Cancer Res."},{"key":"88258_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2020.111182","volume":"135","author":"P Marty","year":"2021","unstructured":"Marty, P. et al. Halofuginone regulates keloid fibroblast fibrotic response to Tgf-\u0392 induction. Biomed. Pharmacother. 135, 111182 (2021).","journal-title":"Biomed. Pharmacother."},{"key":"88258_CR9","doi-asserted-by":"publisher","first-page":"1714","DOI":"10.1136\/annrheumdis-2015-207923","volume":"75","author":"Z Cui","year":"2016","unstructured":"Cui, Z. et al. Halofuginone attenuates osteoarthritis by inhibition of Tgf-\u0392 activity and H-type vessel formation in subchondral bone. Ann. Rheum. Dis. 75, 1714\u20131721 (2016).","journal-title":"Ann. Rheum. Dis."},{"key":"88258_CR10","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1186\/s13046-015-0181-2","volume":"34","author":"PA Assis","year":"2015","unstructured":"Assis, P. A. et al. Halofuginone inhibits phosphorylation of Smad-2 reducing angiogenesis and leukemia burden in an acute promyelocytic leukemia mouse model. J. Exp. Clin. Cancer Res. 34, 65 (2015).","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"88258_CR11","doi-asserted-by":"publisher","first-page":"3373","DOI":"10.1111\/bph.15442","volume":"178","author":"PP Jain","year":"2021","unstructured":"Jain, P. P. et al. Halofuginone, a promising drug for treatment of pulmonary hypertension. Br. J. Pharmacol. 178, 3373\u20133394 (2021).","journal-title":"Br. J. Pharmacol."},{"key":"88258_CR12","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.753727","volume":"12","author":"YY He","year":"2021","unstructured":"He, Y. Y. et al. Identification of hypoxia induced metabolism associated genes in pulmonary hypertension. Front. Pharmacol. 12, 753727 (2021).","journal-title":"Front. Pharmacol."},{"key":"88258_CR13","doi-asserted-by":"publisher","first-page":"2002341","DOI":"10.1183\/13993003.02341-2020","volume":"57","author":"C Guignabert","year":"2021","unstructured":"Guignabert, C. & Humbert, M. Targeting transforming growth factor-\u0392 receptors in pulmonary hypertension. Eur. Resp. J. 57, 2002341 (2021).","journal-title":"Eur. Resp. J."},{"key":"88258_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2019.109640","volume":"121","author":"Y Yue","year":"2020","unstructured":"Yue, Y. et al. Osthole inhibits cell proliferation by regulating the Tgf-\u03921\/Smad\/P38 signaling pathways in pulmonary arterial smooth muscle cells. Biomed. Pharmacother. 121, 109640 (2020).","journal-title":"Biomed. Pharmacother."},{"key":"88258_CR15","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1016\/j.pupt.2013.07.008","volume":"26","author":"Y Bei","year":"2013","unstructured":"Bei, Y. et al. Long-term treatment with fasudil improves bleomycin-induced pulmonary fibrosis and pulmonary hypertension via inhibition of Smad2\/3 phosphorylation. Pulm. Pharmacol. Ther. 26, 635\u2013643 (2013).","journal-title":"Pulm. Pharmacol. Ther."},{"key":"88258_CR16","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2020.607384","volume":"11","author":"Z Yang","year":"2021","unstructured":"Yang, Z. et al. Tsantan sumtang restored right ventricular function in chronic hypoxia-induced pulmonary hypertension rats. Front. Pharmacol. 11, 607384 (2021).","journal-title":"Front. Pharmacol."},{"key":"88258_CR17","doi-asserted-by":"publisher","first-page":"687","DOI":"10.3389\/fphar.2020.00687","volume":"11","author":"YR Bao","year":"2020","unstructured":"Bao, Y. R. et al. Sodium tanshinone II sulfonate a ameliorates hypoxia-induced pulmonary hypertension. Front. Pharmacol. 11, 687 (2020).","journal-title":"Front. Pharmacol."},{"key":"88258_CR18","doi-asserted-by":"publisher","first-page":"3612","DOI":"10.4049\/jimmunol.1701287","volume":"200","author":"J Florentin","year":"2018","unstructured":"Florentin, J. et al. Inflammatory macrophage expansion in pulmonary hypertension depends upon mobilization of blood-borne monocytes. J. Immunol. 200, 3612\u20133625 (2018).","journal-title":"J. Immunol."},{"key":"88258_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2020.106753","volume":"87","author":"M Zhong","year":"2020","unstructured":"Zhong, M., Zhang, X., Shi, X. & Zheng, C. Halofuginone inhibits Lps-induced attachment of monocytes to huvecs. Int. Immunopharmacol. 87, 106753 (2020).","journal-title":"Int. Immunopharmacol."},{"key":"88258_CR20","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0082232","volume":"8","author":"J Liang","year":"2013","unstructured":"Liang, J. et al. Preventive effect of halofuginone on concanavalin a-induced liver fibrosis. PLoS ONE. 8, e82232 (2013).","journal-title":"PLoS ONE."},{"key":"88258_CR21","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1016\/j.bbrc.2016.03.118","volume":"473","author":"XH Sun","year":"2016","unstructured":"Sun, X. H., Fu, J. & Sun, D. Q. Halofuginone alleviates acute viral myocarditis in suckling Balb\/C mice by inhibiting Tgf-\u03921. Biochem. Biophys. Res. Commun. 473, 558\u2013564 (2016).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"88258_CR22","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1189\/jlb.0705409","volume":"80","author":"M Leiba","year":"2006","unstructured":"Leiba, M. et al. Halofuginone inhibits Nf-Kappab and P38 Mapk in activated T cells. J. Leukoc. Biol. 80, 399\u2013406 (2006).","journal-title":"J. Leukoc. Biol."},{"key":"88258_CR23","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1142\/S0192415X21500208","volume":"49","author":"H Huang","year":"2021","unstructured":"Huang, H., Kong, L., Luan, S., Qi, C. & Wu, F. Ligustrazine suppresses platelet-derived growth factor-BB-induced pulmonary artery smooth muscle cell proliferation and inflammation by regulating the PI3K\/Akt signaling pathway. Am. J. Chin. Med. 49, 437\u2013459 (2021).","journal-title":"Am. J. Chin. Med."},{"key":"88258_CR24","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/1465-9921-13-27","volume":"13","author":"R Quarck","year":"2012","unstructured":"Quarck, R. et al. Characterization of proximal pulmonary arterial cells from chronic thromboembolic pulmonary hypertension patients. Respir. Res. 13, 27 (2012).","journal-title":"Respir. Res."},{"key":"88258_CR25","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1093\/aob\/mcq243","volume":"107","author":"W Strzalka","year":"2011","unstructured":"Strzalka, W. & Ziemienowicz, A. Proliferating cell nuclear antigen (Pcna): A key factor in dna replication and cell cycle regulation. Ann. Bot. 107, 1127\u20131140 (2011).","journal-title":"Ann. Bot."},{"key":"88258_CR26","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1016\/j.tcb.2022.03.010","volume":"32","author":"VK Gupta","year":"2022","unstructured":"Gupta, V. K. & Chaudhuri, O. Mechanical regulation of cell-cycle progression and division. Trends Cell Biol. 32, 773\u2013785 (2022).","journal-title":"Trends Cell Biol."},{"key":"88258_CR27","doi-asserted-by":"publisher","first-page":"2935","DOI":"10.3390\/ijms22062935","volume":"22","author":"P Lukasik","year":"2021","unstructured":"Lukasik, P., Zaluski, M. & Gutowska, I. Cyclin-dependent kinases (Cdk) and their role in diseases development-review. Int. J. Mol. Sci. 22, 2935 (2021).","journal-title":"Int. J. Mol. Sci."},{"key":"88258_CR28","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1016\/S0006-2952(01)00753-5","volume":"62","author":"M Pines","year":"2001","unstructured":"Pines, M. et al. Reduction in dermal fibrosis in the tight-skin (Tsk) mouse after local application of halofuginone. Biochem. Pharmacol. 62, 1221\u20131227 (2001).","journal-title":"Biochem. Pharmacol."},{"key":"88258_CR29","doi-asserted-by":"publisher","first-page":"18970","DOI":"10.1002\/jcp.28537","volume":"234","author":"X Xia","year":"2019","unstructured":"Xia, X. et al. Mir-31 shuttled by halofuginone-induced exosomes suppresses Mfc-7 cell proliferation by modulating the Hdac2\/cell cycle signaling axis. J. Cell. Physiol. 234, 18970\u201318984 (2019).","journal-title":"J. Cell. Physiol."},{"key":"88258_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.pdpdt.2021.102572","volume":"37","author":"T Lv","year":"2022","unstructured":"Lv, T. et al. Halofuginone enhances the anti-tumor effect of Ala-Pdt by suppressing Nrf2 signaling in Cscc. Photodiagn. Photodyn. Ther. 37, 102572 (2022).","journal-title":"Photodiagn. Photodyn. Ther."},{"key":"88258_CR31","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1007\/s00441-005-0092-1","volume":"324","author":"Y Gnainsky","year":"2006","unstructured":"Gnainsky, Y. et al. Involvement of the tyrosine phosphatase early gene of liver regeneration (Prl-1) in cell cycle and in liver regeneration and fibrosis effect of halofuginone. Cell Tissue Res. 324, 385\u2013394 (2006).","journal-title":"Cell Tissue Res."},{"key":"88258_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ejphar.2017.12.010","volume":"820","author":"N Zhang","year":"2018","unstructured":"Zhang, N., Dong, M., Luo, Y., Zhao, F. & Li, Y. Danshensu prevents hypoxic pulmonary hypertension in rats by inhibiting the proliferation of pulmonary artery smooth muscle cells via Tgf-\u0392-Smad3-associated pathway. Eur. J. Pharmacol. 820, 1\u20137 (2018).","journal-title":"Eur. J. Pharmacol."},{"key":"88258_CR33","doi-asserted-by":"publisher","first-page":"2585","DOI":"10.3390\/ijms19092585","volume":"19","author":"N Rol","year":"2018","unstructured":"Rol, N., Kurakula, K. B., Happe, C., Bogaard, H. J. & Goumans, M. J. Tgf-\u0392 and Bmpr2 signaling in Pah: Two black sheep in one family. Int. J. Mol. Sci. 19, 2585 (2018).","journal-title":"Int. J. Mol. Sci."},{"key":"88258_CR34","doi-asserted-by":"crossref","unstructured":"Derynck, R. & Budi, E. H. Specificity, versatility, and control of Tgf-\u0392 family signaling. Sci. Signal. 12, eaav5183 (2019).","DOI":"10.1126\/scisignal.aav5183"},{"key":"88258_CR35","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1002\/jcp.30529","volume":"237","author":"S Aashaq","year":"2022","unstructured":"Aashaq, S. et al. Tgf-\u0392 signaling: A recap of smad-independent and smad-dependent pathways. J. Cell. Physiol. 237, 59\u201385 (2022).","journal-title":"J. Cell. Physiol."},{"key":"88258_CR36","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2021.814222","volume":"8","author":"P Andre","year":"2022","unstructured":"Andre, P. et al. Therapeutic approaches for treating pulmonary arterial hypertension by correcting imbalanced Tgf-\u0392 superfamily signaling. Front. Med. 8, 814222 (2022).","journal-title":"Front. Med."},{"key":"88258_CR37","doi-asserted-by":"publisher","first-page":"2751","DOI":"10.3892\/mmr.2016.4874","volume":"13","author":"L Li","year":"2016","unstructured":"Li, L. et al. Tgf-\u03921 inhibits the apoptosis of pulmonary arterial smooth muscle cells and contributes to pulmonary vascular medial thickening via the Pi3K\/Akt pathway. Mol. Med. Rep. 13, 2751\u20132756 (2016).","journal-title":"Mol. Med. Rep."},{"key":"88258_CR38","doi-asserted-by":"crossref","unstructured":"Abeyrathna, P., Kovacs, L., Han, W. & Su, Y. Calpain-2 Activates Akt Via Tgf-\u03921-Mtorc2 Pathway in Pulmonary Artery Smooth Muscle Cells. Am. J. Physiol.-Cell Physiol. 311, C24-C34 (2016).","DOI":"10.1152\/ajpcell.00295.2015"},{"key":"88258_CR39","first-page":"4988","volume":"24","author":"Y Zhang","year":"2020","unstructured":"Zhang, Y., Yuan, R. X. & Bao, D. Tgf-\u03921 promotes pulmonary arterial hypertension in rats via activating Rhoa\/Rock signaling pathway. Eur. Rev. Med. Pharmacol. Sci. 24, 4988\u20134996 (2020).","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"88258_CR40","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1016\/j.bbrc.2017.07.020","volume":"490","author":"YX Li","year":"2017","unstructured":"Li, Y. X., Run, L., Shi, T. & Zhang, Y. J. Ctrp9 regulates hypoxia-mediated human pulmonary artery smooth muscle cell proliferation, apoptosis and migration via Tgf-Beta1\/Erk1\/2 signaling pathway. Biochem. Biophys. Res. Commun. 490, 1319\u20131325 (2017).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"88258_CR41","first-page":"41","volume":"51","author":"J Wang","year":"2023","unstructured":"Wang, J. et al. The effect of halofuginone on cardiopulmonary function and its mechanism in rats with high-altitude pulmonary hypertension. Tianjin. Med. J. 51, 41\u201344 (2023).","journal-title":"Tianjin. Med. J."},{"key":"88258_CR42","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.jnutbio.2016.07.006","volume":"36","author":"H Jin","year":"2016","unstructured":"Jin, H. et al. Grape seed procyanidin extract attenuates hypoxic pulmonary hypertension by inhibiting oxidative stress and pulmonary arterial smooth muscle cells proliferation. J. Nutr. Biochem. 36, 81\u201388 (2016).","journal-title":"J. Nutr. Biochem."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-88258-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-88258-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-88258-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,29]],"date-time":"2025-01-29T04:33:52Z","timestamp":1738125232000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-88258-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,29]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["88258"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-88258-z","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,29]]},"assertion":[{"value":"3 April 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"3619"}}